Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Invictus MD Strategies Corp > Invictus' rates well in Alan Brochstein's Newsletter
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(15)
•••
Comment by CommodityCowboyon Aug 11, 2019 7:51pm
149 Views
Post# 30016563

RE:Invictus' rates well in Alan Brochstein's Newsletter

RE:Invictus' rates well in Alan Brochstein's NewsletterI toured and bought into a cucumber farm in Airdrie a few years ago who were awaiting a cultivation license from Health Canada at the time. They just uplisted on the Nasdaq in the last couple weeks under SNDL. I was really hoping Invictus would stay super low till my shares split and unrestricted a few months from now, but I imagine they'll recover before I can truly capitalize. Not the worst problem to have as I'll win either way. This company is so undervalued under Dixon and its current trajectory its insane.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities